Meso-Xanthin F199® – 1 x 1.5ml

Product benefits

Key ingredients

Administration

Meso-Xanthin F199® is designed for adults aged 21 and over. It’s particularly suited to those over the age of 40-45. A single 1.5ml syringe can treat the face, neck and chest regions. Prior to administration, remove any makeup if applied, and clean the skin three times with a 0.05% chlorhexidine solution beforehand. The application of local anaesthetic cream is permitted if desired.

Frequency of treatment: 6 treatments at 7-14 day intervals for those both over and under 50 years of age.

Recommended needle size: 32g x 4mm. Please note: use of a needle gauge larger than 32g can result in incorrect product distribution.

Meso-Xanthin F199® is administered using a thin gauge needle (32g), inserted at approximately a 45° angle to the facial skin’s surface at a depth of 2-4mm, with points spaced 0.8-1 cm apart. For the neck, the needle is introduced at a 30° angle, 1-2mm deep. Proper administration involves mid-dermis injections, ensuring care is taken to avoid injecting into the deep dermis. A micro-papular technique can be utilised in the periorbital region. For this, the needle is inserted parallel to the skin at a depth of 2-3mm, with the bevel oriented upwards for better control during administration. Each point administers 0.05ml of product, spaced 4-5mm apart. To address undereye dark circles and wrinkles, the technique involves administering 0.05ml per point using a superficial micro-papule approach. With this method, the needle is inserted 1-2 mm deep with the bevel oriented upwards, covering the entire periorbital area for optimal results.

The average volume per treatment session is dependent on the site(s) as well as the amount of correction desired. Based on clinical observations, the maximum recommended dose per session is 1.5ml per person across the face and neck.

Contraindications and side effects

Meso-Xanthin F199® has an intense regenerative effect, restoring blood supply to the skin tissue, which results in a decrease of the effects brought on by anti-wrinkle injections. Therefore, it is recommended 14 days prior to or 14 days after administration of anti-wrinkle injections. Additionally, hyaluronic acid-based fillers may be administered in a 14-day interval before or after the administration of Meso-Xanthin F199® treatment. If administered after, take care to avoid site(s) of HA.

Contraindications include individuals who have a history of severe allergies or anaphylaxis, those who have experienced previous hypersensitivity to any of Meso-Xanthin F199®’s active ingredients, including hyaluronic acid, and those with bleeding disorders. Product administration should not be performed in areas other than fat tissue layers.

Delay treatment in areas where there is an active inflammatory response or skin eruptions until these have resolved. Before administration, review the client’s medical history to identify indications and contraindications – including allergies and tissue sensitivity.

High doses of Vitamin A or E supplements, aspirin, or non-steroidal anti-inflammatory medications should be avoided before treatment, as these can increase bleeding or bruising at the administration site(s). Sites should also not be exposed to severe cooling, indoor tanning, or sauna/steam baths shortly before treatment.

After treatment with Meso-Xanthin F199®, reactions may occur and continue for 1-3 days. These include redness, swelling, itching, tenderness, and change in skin colour at the injection site(s). Other known potential adverse effects reported during post-market surveillance include short-term erythema, edema, pruritus, or moderate soreness in the injection site(s) for 1 to 3 days.

Post-treatment

Following treatment, it is recommended to avoid makeup for at least 24 hours. Protect treatment sites from exposure to wind and frost. During the course of treatment, it is important to refrain from using indoor tanning beds, saunas, and steam baths. Lastly, strenuous physical activity or sports should be avoided for at least 48 hours post-treatment, as these may cause temporary redness, swelling, or itching at the treated site(s). Store away from sunlight at 2-25°C. Device must be used prior to the printed expiration date. Do not freeze, reuse, or re-sterilise. Keep out of reach of children.